| Relative risk at extremes | Gail model | Claus model | BRCAPRO model | Cuzick–Tyrer model | BOADICEA model |
---|---|---|---|---|---|---|
Prediction | Â | Â | Â | Â | Â | Â |
   Amir and colleagues' [27] validation study ratioa |  | 0.48 | 0.56 | 0.49 | 0.81 | Not assessed |
   95% confidence interval [27] |  | 0.54–0.90 | 0.59–0.99 | 0.52–0.80 | 0.85–1.41 | Not assessed |
Personal information | Â | Â | Â | Â | Â | Â |
   Age (20–70 years) | 30 | Yes | Yes | Yes | Yes | Yes |
   Body mass index | 2 | No | No | No | Yes | No |
   Alcohol intake (0–4 units) daily | 1.24 | No | No | No | No | No |
Hormonal/reproductive factors | Â | Â | Â | Â | Â | Â |
   Age at menarche | 2 | Yes | No | No | Yes | No |
   Age at first live birth | 3 | Yes | No | No | Yes | No |
   Age at menopause | 4 | No | No | No | Yes | No |
   Hormone replacement therapy use | 2 | No | No | No | Yes | No |
   Oral contraceptive pill use | 1.24 | No | No | No | No | No |
   Breast feeding | 0.8 | No | No | No | No | No |
   Plasma oestrogen | 5 | No | No | No | No | No |
Personal breast disease | Â | Â | Â | Â | Â | Â |
   Breast biopsies | 2 | Yes | No | No | Yes | No |
   Atypical ductal hyperplasia | 3 | Yes | No | No | Yes | No |
   Lobular carcinoma in situ | 4 | No | No | No | Yes | No |
   Breast density | 6 | No | No | No | No | No |
Family history | Â | Â | Â | Â | Â | Â |
   First-degree relatives | 3 | Yes | Yes | Yes | Yes | Yes |
   Second-degree relatives | 1.5 | No | Yes | Yes | Yes | Yes |
   Third-degree relatives |  | No | No | No | No | Yes |
   Age of onset of breast cancer | 3 | No | Yes | Yes | Yes | Yes |
   Bilateral breast cancer | 3 | No | No | Yes | Yes | Yes |
   Ovarian cancer | 1.5 | No | No | Yes | Yes | Yes |
   Male breast cancer | 3–5 | No | No | Yes | No | Yes |